Table 2.
Clinicopathological characteristics of 42 surgically confirmed PTC patients.
| Clinicopathological characteristics | Value | PC expression | P | ||
|---|---|---|---|---|---|
| High | Low | ||||
| Gender | |||||
| male | 14 | 5 | 9 | 0.491 | |
| female | 28 | 7 | 21 | ||
| Age (Y), Mean ± SD | 42.3 ± 1.9 | ||||
| ≥55, n (%) | 8 (19.0%) | 3 | 5 | 0.668 | |
| <55, n (%) | 34 (81.0%) | 9 | 25 | ||
| Tumor size (mm) | ≥5, n (%) | 33 (78.6%) | 11 | 27 | 1 |
| <5, n (%) | 9 (21.4%) | 1 | 3 | ||
| CLNM | Positive | 15 (35.7%) | 11 | 16 | 0.031* |
| Negative | 27 (64.3%) | 1 | 14 | ||
| Extrathyroidal extension | Positive | 27 (64.3%) | 6 | 9 | 0.292 |
| Negative | 15 (35.7%) | 6 | 21 | ||
| Multifocal tumor | Positive | 14 (33.3%) | 6 | 8 | 0.169 |
| Negative | 28 (66.7%) | 6 | 22 | ||
| Bilateral distribution | Positive | 21 (50%) | 7 | 14 | 0.734 |
| Negative | 21 (50%) | 5 | 16 | ||
| TNM stage | I + II | 29 (69%) | 8 | 21 | 1 |
| III + IV | 13 (31%) | 4 | 9 | ||
PTC, papillary thyroid carcinoma; CLNM, central lymph nodal metastasis; PC, pyruvate carboxylase, TNM, tumor-node-metastasis. *P <0.05.